Bristol Myers Squibb Co (BMY): Dividends Paid
$5.04B
Year ended 2025-12-31
$5.09B
Trailing 12 months to 2026-06-30
+2.9%
3-year compound annual growth
+4.4%
5-year compound annual growth
+7.4%
10-year compound annual growth
| Period ended | Dividends Paid | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $5.04B | +3.7% | 2026-02-11, From 2025-01-01 |
| 2024-12-31 | $4.86B | +2.5% | 2026-02-11, From 2024-01-01 |
| 2023-12-31 | $4.74B | +2.4% | 2026-02-11, From 2023-01-01 |
| 2022-12-31 | $4.63B | +5.4% | 2025-02-12, From 2022-01-01 |
| 2021-12-31 | $4.40B | +7.9% | 2024-02-13, From 2021-01-01 |
| 2020-12-31 | $4.08B | +52.1% | 2023-02-14, From 2020-01-01 |
| 2019-12-31 | $2.68B | +2.5% | 2022-02-09, From 2019-01-01 |
| 2018-12-31 | $2.61B | +1.4% | 2021-02-10, From 2018-01-01 |
| 2017-12-31 | $2.58B | +1.2% | 2020-02-24, From 2017-01-01 |
| 2016-12-31 | $2.55B | +2.8% | 2019-02-25, From 2016-01-01 |
| 2015-12-31 | $2.48B | +3.3% | 2018-02-13, From 2015-01-01 |
| 2014-12-31 | $2.40B | +3.9% | 2017-02-21, From 2014-01-01 |
| 2013-12-31 | $2.31B | +1.0% | 2016-02-12, From 2013-01-01 |
| 2012-12-31 | $2.29B | +1.4% | 2015-02-13, From 2012-01-01 |
| 2011-12-31 | $2.25B | +2.4% | 2014-02-14, From 2011-01-01 |
| 2010-12-31 | $2.20B | -11.3% | 2013-02-15, From 2010-01-01 |
| 2009-12-31 | $2.48B | +0.9% | 2012-02-17, From 2009-01-01 |
| 2008-12-31 | $2.46B | +11.2% | 2011-02-18, From 2008-01-01 |
| 2007-12-31 | $2.21B | n/a | 2010-02-19, From 2007-01-01 |
Dividends Paid at similar companies
| Company | Year ended | Dividends Paid | Change YoY |
|---|---|---|---|
| Bristol Myers Squibb Co (BMY) | 2025-12-31 | $5.04B | +3.7% |
| Abbott Laboratories (ABT) | 2025-12-31 | $4.12B | +7.3% |
| AbbVie Inc. (ABBV) | 2025-12-31 | $11.66B | +5.7% |
| Merck & Co., Inc. (MRK) | 2025-12-31 | $8.18B | +4.3% |
| Eli Lilly & Co (LLY) | 2025-12-31 | $5.38B | +15.0% |
| Regeneron Pharmaceuticals, Inc. (REGN) | 2025-12-31 | $370.30M | n/a |
| Organon & Co. (OGN) | 2025-12-31 | $88.00M | -70.4% |
| Perrigo Co PLC (PRGO) | 2025-12-31 | $159.30M | +4.5% |
| Phibro Animal Health Corp (PAHC) | 2026-06-30 | $19.46M | +0.1% |
Compare BMY, ABT, ABBV, MRK side by side · Screen every company in Pharmaceutical Preparations ↗